Elevance Health

ELV

Market cap $78.7B

ELV's third-quarter earnings may face pressure as rising costs and weaker Medicaid memberships offset premium gains.

Elevance Health (ELV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

SAN DIEGO , Oct. 14, 2025 /PRNewswire/ -- The Shareholders Foundation, Inc. announces that an update in the lawsuit that is currently pending for certain investors in Elevance Health, Inc. (NYSE: ELV) shares. Investors who purchased shares of Elevance Health, Inc. (NYSE: ELV) prior to April 2024 and continue to hold any of those NYSE: ELV shares have also certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Share of only a handful of large-cap US insurers finished the week in negative territory, while the majority of insurers were either flat or saw gains as Congress failed to reach an agreement to keep the federal government open. The S&P 500 was up about 1.1% for the week as of close of business Oct. 2 as the broader market seemed to brush off concerns associated with the shutdown.

@OptionsPlay's Tony Zhang says he's been "bullish for quite some time" on Meta Platforms (META) due to how it uses A.I. to boost advertising revenue.

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) will release third quarter 2025 financial results on October 21, 2025, at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 - Access Code - 3972058 (Domestic) 312-470-0178 - Access Code - 3972058 (International) 800-.

Elevance Health is significantly undervalued, trading at a 41% discount to industry peers, despite strong revenue growth and a 2.11% dividend yield. ELV's recent selloff was triggered by bottom-line contraction and lowered FY2025 EPS guidance, but revenue growth remains robust, especially in its Carelon segment. Despite margin pressures from rising Medicaid and ACA costs, ELV maintains strong profitability, low leverage, and shareholder-friendly capital allocation, supporting a defensive investment thesis.

INDIANAPOLIS--(BUSINESS WIRE)--Indianapolis Public Schools' Northwest Middle School today celebrated the unveiling of its newly transformed weight room, a project made possible through a partnership with Elevance Health and the Impact Fitness Foundation (IFF). The initiative is part of Elevance Health's ongoing commitment to the whole health of communities and is the fourth fitness space upgrade made in an Indianapolis school, in celebration of the Elevance Health Women's Fort Myers Tipoff, a p.

CE, ELV and ARR have been added to the Zacks Rank #5 (Strong Sell) List on September 15, 2025.

ELV exits Part D and trims Medicare Advantage markets, betting on stronger-margin plans to protect profitability.